Thus, it is important to take into account the CRC stage and tumour microenvironment when interpreting the role of E2–GPER interactions in colon cancer tumorigenesis, sex differences, and patient survival/treatment [170]. This evidence concerns the gene GPER1 and colorectal carcinoma.